Vector Laboratories Publishes New Guide for Immunofluorescence
Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, announced today the availability of a new guide for the growing field of immunofluorescence (IF). This new 32-page resource covers all aspects of IF and its implementation, including history of the technique’s development, the IF workflow and tips on choosing the right reagents for the application. The IF Guide, which is available in print and online, can be requested at no charge or downloaded at: http://info.vectorlabs.com/ifguide
In this new guide, Vector Laboratories presents easy-to-use charts and information on detection system choices, the different types of reagents that can be used and the importance of choosing the right mounting media and accessory reagents. The colorful guide is illustrated throughout with images produced using Vector Laboratories’ technology.
“Immunofluorescence is an excellent tool in the immunohistochemistry lab, providing resolution and sensitivity that many tissue studies demand,” explains Harjit Kullar, vice president of marketing for Maravai LifeSciences. “This new guide is a representation of Vector Laboratories’ commitment to developing technologies that drive the IF field forward.”
About Vector Laboratories
Vector Laboratories develops, manufactures and markets labeling and detection reagents for immunohistochemistry, immunofluorescence, DNA/RNA and glycobiology. The company serves customers in disease and therapeutics research with tools that help them precisely visualize and study tissues and cells. A pioneer in a number of innovative technologies, Vector Laboratories has been providing a continuous stream of reliable tools to its customers for more than 40 years. With headquarters in Burlingame, California and a subsidiary in Peterborough, U.K., the company maintains a network of more than 40 distributors across the globe. A privately held company, Vector Laboratories was acquired by Maravai LifeSciences in 2016.
Contacts for the media:
David Weber, Chief Commercial Officer